The DOI matches its Crossref record.
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera
Open accessAbstract
Key Points: The novel IFNα-2b, ropeginterferon alfa-2b, administered once every 2 weeks has low toxicity and induces high and sustained response rates in polycythemia vera patients. Ropeginterferon alfa-2b induces significant partial and complete molecular response rates, as reflected by reduction of JAK2 allelic burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Barbui, T., Tefferi, A., Vannucchi, A. M., Passamonti, F., Silver, R. T., Hoffman, R., Verstovsek, S., Mesa, R., Kiladjian, J.-J., Hehlmann, R., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0077-1 · Cited by 566
Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-Kyuchukova, L., Egyed, M., Rossiev, V., Dulicek, P., Illes, A., Pylypenko, H., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30236-4 · Cited by 367
Self-citationDiagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
Rumi, E., & Cazzola, M. (2017) · Blood · doi:10.1182/blood-2016-10-695957 · Cited by 258
Mills, M., Emori, C., Kumar, P., Boucher, Z., George, J., & Bolcun-Filas, E. (2025) · Developmental Biology · doi:10.1016/j.ydbio.2024.09.007 · Cited by 12
Metadata
- Authors
- Gisslinger, H., Zagrijtschuk, O., Buxhofer-Ausch, V., Thaler, J., Schloegl, E., Gastl, G. A., Wolf, D., Kralovics, R., Gisslinger, B., Strecker, K., Egle, A., Melchardt, T., Burgstaller, S., Willenbacher, E., Schalling, M., Them, N. C., Kadlecova, P., Klade, C., & Greil, R.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2015-10-08
- Volume
- 126
- Issue
- 15
- Pages
- 1762-1769
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2292715199
- Cited by
- 193
- References
- 0
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera. https://app.cochat.ai/papers/10.1182/blood-2015-04-637280
- The paper
- Gisslinger, H., Zagrijtschuk, O., Buxhofer-Ausch, V., Thaler, J., Schloegl, E., Gastl, G. A., Wolf, D., Kralovics, R., Gisslinger, B., Strecker, K., Egle, A., Melchardt, T., Burgstaller, S., Willenbacher, E., Schalling, M., Them, N. C., Kadlecova, P., Klade, C., & Greil, R. (2015). Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera. Blood. https://doi.org/10.1182/blood-2015-04-637280
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.